Global Women’s Health Drugs Market to 2024 – Influx of New Products Including Orilissa, Relugolix and Bremelanotide

Global Women’s Health Drugs Market to 2024 Research Report provides Key Marketed Products, Pipeline Landscape Assessment, Company Analysis and Positioning, Revenue and Market Share and Strategic Consolidations.

Pune, India - February 12, 2019 /MarketersMedia/ —

The women’s health therapy area covers medical disorders that affect females only, primarily disorders of the female reproductive system, including those associated with menstruation, conception, pregnancy, childbirth and menopause. Many of these disorders are highly prevalent among the female population.

The Women’s Health Market is relatively small considering the high prevalence of many women’s health indications. However, robust growth is projected over the forecast period due to the influx of a number of new products.

This report covers all indications within women’s health with a particular focus on five key indications: endometriosis, polycystic ovarian syndrome (PCOS), cervical intraepithelial neoplasia (CIN), menopausal disorders and infertility.

*Company Analysis and Positioning:
Revenue and Market Share Analysis by Company
1 Bayer AG - Company to Remain a Market Leader within Women’s Health
2 AbbVie Inc - Orilissa to Reach Blockbuster Status, Boosting Company’s Market Share
3 Allergan - Revenue Gains From Fibristal, Lo Loestrin Fe and Liletta to Offset Losses from Minastrin 24 Fe and Estrace
4 Merck & Co. - Company to Remain a Key Player Due to Growth of Gardasil/Gardasil 9
5 GlaxoSmithKline - Cervarix and Retosiban to Drive Strong Growth
6 Pfizer - How will patent expiration affect revenues for women’s health market?
7 TherapeuticsMD – Women’s Health Specialist to Gain Considerable Market Share by 2024

Get Discount on Global Women’s Health Drugs Market Research Report at https://www.reportsnreports.com/contacts/discount.aspx?name=1854865

Scope
- There are 277 pipeline products in active development for women’s health disorders. Which molecule types and molecular targets are most prominent within the pipeline?
- Merck&Co and Bayer currently represent leading companies within women’s health. Will they maintain this dominance over the forecast period?
- Gardasil, Mirena and Nuvaring and are among the most lucrative drugs within the women’s health market. Which of these will experience a considerable decline in revenue over the forecast period following loss of patent protection?
- The influx of a number of recent market entrants and late-stage pipeline products will have a considerable impact on the women’s health market over the forecast period. Which of these drugs are projected to achieve blockbuster status by 2024?
- In total, 246 licensing deals relating to women’s health products have been completed since 2006. Which types of assets attracted the largest deal values?

Direct Purchase of this Research Report at https://www.reportsnreports.com/purchase.aspx?name=1854865

Reasons to buy:
- Understand the current treatment landscape, with portfolios of key marketed products and a focus on historical and forecast sales patterns, and an overview of each drug’s mechanism of action.
- Analyze the women’s health pipeline through a comprehensive review of the pipeline segmented by stage of development, molecule type and molecular target.
- Consider market opportunities and potential risks by examining trends in clinical trial duration and size, as well as clinical trial failure rates.
- Predict growth in market size by examining multi-scenario forecasting trends from 2017 to 2024 and determine the contributions that different products and companies will make to this growth.
- Identify commercial opportunities in the women’s health deals landscape by analyzing trends in licensing and co-development deals.

Contact Info:
Name: Vishal Kalra
Email: Send Email
Organization: ReportsnReports
Website: https://www.reportsnreports.com/reports/1854865-global-womens-health-drugs-market-to-2024-influx-of-new-products-including-orilissa-relugolix-and-bremelanotide-to-diversify-landscape-and-drive-growth.html

Source URL: https://marketersmedia.com/global-womens-health-drugs-market-to-2024-influx-of-new-products-including-orilissa-relugolix-and-bremelanotide/481772

Source: MarketersMedia

Release ID: 481772

More News From The World Insiders

'Digital gangsters': UK wants tougher rules for Facebook

Feb 18, 2019

LONDON — British lawmakers issued a scathing report Monday that calls for tougher rules to keep Facebook and other tech firms from acting like "digital gangsters" and intentionally violating data privacy and competition laws. The report on fake news and disinformation on social media sites followed an 18-month investigation by Parliament's influential media committee. The committee recommended that social media sites should have to follow a mandatory code of ethics overseen by an independent regulator to better control harmful or illegal content. The report called out Facebook in particular, saying that the site's structure seems to be designed to "conceal...

Brex-split: 7 lawmakers quit Labour over EU, anti-Semitism

Feb 18, 2019

LONDON — Seven British lawmakers quit the main opposition Labour Party on Monday over its approach to issues including Brexit and anti-Semitism — the biggest shake-up in years for one of Britain's major political parties. The announcement ripped open a long-simmering rift between socialists and centrists in the party, which sees itself as the representative of Britain's working class. It's also the latest fallout from Britain's decision to leave the European Union, which has split both of the country's two main parties — Conservatives and Labour — into pro-Brexit and pro-EU camps. Many Labour lawmakers have been unhappy with the...

Former head of Alternative for Germany on trial for perjury

Feb 18, 2019

BERLIN — The former head of far-right Alternative for Germany party has appeared in court on charges of perjury. Frauke Petry appeared Monday before the regional court in Dresden to defend herself against accusations that she made false statements to parliament while under oath. Petry has previously acknowledged making erroneous statements about the nature of loans that members made to the party during an election campaign, but denied doing so intentionally. A ruling is expected next month. The 43-year-old left Alternative for Germany after the country's 2017 national election and founded her own party, which plans to contest this year's...

School threat system fields thousands of tips in first month

Feb 18, 2019

HARRISBURG, Pa. — A threat reporting system now required for all Pennsylvania schools fielded more than 4,900 tips in its first month, about a third of them considered serious enough to pass along to local police and school officials. The goal of the Safe 2 Say Something program, which funnels tips to an around-the-clock call center at the attorney general's headquarters in Harrisburg, is to respond to troubling behavior, unsafe school situations and anything else tipsters deems appropriate to report. The program passed the Legislature with near unanimity last year, mandating it encompass all K-12 students in Pennsylvania, including charter,...

Australia blames 'state actor' for hacking political parties

Feb 18, 2019

CANBERRA, Australia — A "sophisticated state actor" was behind a cyberattack on the Australian Parliament's computing network that also affected the network used by major political parties, the prime minister said Monday. Prime Minister Scott Morrison did not identify the state behind what he described as a "malicious intrusion" on Feb. 8. A joint statement from House of Representatives Speaker Tony Smith and Senate President Scott Ryan said at the time that there was no evidence that data had been accessed in the breach. But lawmakers were advised to change passwords. Morrison revealed Monday that the computer networks used by...

About Us

The World Insiders brings you exclusive coverage from across the globe in a timely, easy to consume format sourced directly from our regional media partners.

Contact us: sales[at]theworldinsiders.com

Subscribe Now!